+157.2%
MRNA vs BDX
+10.1%
+147.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | BDX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.8% | +4.6% | +3.7% |
| 7D | -1.1% | -3.2% | +2.1% | +5.5% |
| 30D | +126.1% | -2.5% | +128.7% | +142.8% |
| 3M | +190.0% | +21.4% | +168.6% | +185.3% |
| 6M | +157.2% | +10.4% | +146.8% | +200.1% |
| All | +157.2% | +10.1% | +147.1% | +200.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BDX.
Daily Out/Under-Performance
Portfolio return minus BDX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BDX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded BDX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling